Baxter International Inc. (BAX)

92.67
NYSE : Health Technology
Prev Close 93.06
Day Low/High 92.24 / 93.16
52 Wk Low/High 72.42 / 95.00
Avg Volume 2.34M
Exchange NYSE
Shares Outstanding 510.56M
Market Cap 47.51B
EPS 3.00
P/E Ratio 31.12
Div & Yield 0.88 (0.91%)
Off the Charts

Off the Charts

Market weakness short-lived again,

Two Shorts in Health Sector

Two Shorts in Health Sector

Showing signs of technical deterioration.

Call Buy in Baxter

Call Buy in Baxter

Dan Passarelli says Baxter International's stock has been trending higher since June. A recent buy signal was triggered at current support, and its implied volatility is low. Dan is looking at buying the May 70 calls outright in BAX.

Market on Close Imbalances

How much to sell? My mavens on the floor of the exchange see $550 million to sell on the close. On the sector sell side is financials at $250 million, consumer staples at $80 million and consumer discretionary at $75 million. There are no buys. In t...

Stocks Under $10: Chase This Winner?

Stocks Under $10: Chase This Winner?

Portfolio Mgr. David Peltier analyzes one of the early low-dollar winners of 2013.

A Pair of Earnings Plays

A Pair of Earnings Plays

MICROS Systems and Baxter International have very different, but tradable, charts.

Stocks Under $5: Stealth Health Care Play

Stocks Under $5: Stealth Health Care Play

Portfolio Mgr. David Peltier uncovers a low-dollar healthcare stock with big growth potential.

Stocks Under $10: At an Inflection Point

Stocks Under $10: At an Inflection Point

Portfolio Mgr. David Peltier analyzes a low-dollar stock on the verge of a potential turnaround.

Baxter to Buy Competitor Gambro for $2.8 Billion: Hot Trends

Baxter to Buy Competitor Gambro for $2.8 Billion: Hot Trends

A look at the day's most searched trends on the Web, including Baxter International after the company said it will buy Swiss competitor Gambro for 18.3 billion kronor ($2.8 billion).

MedTech sector upgraded at BMO

Baxter downgraded at Deutsche

Baxter rated new Outperform at BMO

Many Signs of a Top

Many Signs of a Top

The charts suggest staying away from the long side and even putting on short positions.

Fitz Bits: Wait to Embrace the Uptrend

Fitz Bits: Wait to Embrace the Uptrend

For Baxter, wait for a pullback to this key level before you dive in.

What's Ahead for This Run

What's Ahead for This Run

The next resistance for the S&P appears to be the familiar 1358 level.

Cowen Healthcare Conf.

Try Baxter for Healthy Total Returns

Try Baxter for Healthy Total Returns

If you're nervous about the overall market it might be nice to have a low-beta stock like BAX.

Baxter estimates cut at Morgan Stanley

Analyst Actions -- 10/21/2011

Here are today's top research calls.

Analyst Actions -- 10/12/2011

Here are today's top research calls.

Analyst Actions -- 9/27/2011

Here are today's top research calls.

Where Is the Leadership?

Where Is the Leadership?

Actions of our politicians have a deleterious effect on consumer and investor confidence.

Remain Cautious

Remain Cautious

In bear markets -- and this seems to be one -- rallies are meant for selling.